Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development ... (ChemGenex data and analyses. About ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations

Date:10/21/2010

ChemGenex data and analyses.

About Cephalon, Inc.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at www.cephalon.com.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutic
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation

Post Your Comments:

(Date:5/22/2013)... WILMINGTON, Del. and MUNICH , ... venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation ... today its first interim results of the J enaValve ... Safety I n Pa T ients with S E ... Paris . JUPITER is a post-market registry ...

(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling. While more than half of these ... hyperhidrosis is a serious medical condition. Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...

(Date:5/22/2013)... 22, 2013 Healthcare providers are turning ... management (ECM) solution, for a deeper ... . These organizations identified enterprise content management ... use OnBase to optimize their Meditech system ... (Logo: http://photos.prnewswire.com/prnh/20090130/65710LOGO ) ...

Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2 First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3 First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4 Is There Finally A Way To Stop Severe Excessive Sweating? 2 Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2 Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3

[0] First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System [0] Is There Finally A Way To Stop Severe Excessive Sweating?[0] Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System

... the constructability-focused structural engineering firm, has completed its design-build ... Willard, OH. Ruby acted as the engineer of record ... third in a series of construction projects for Mercy. ... Heart Pavilion in Toledo and Mercy Hospital of Tiffin, ...

... Pharmaceuticals, Inc. (AMEX: AEN ), a developer ... announced today that it will hold its 2nd quarter ... at 2:00pm EDT. James S. Kuo, M.D., M.B.A., Adeona,s ... Company,s drug development programs and commercialization efforts of ...

Cached Medicine Technology:Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project 2 Adeona to Host Second Quarter 2011 Investor Conference Call 2 Adeona to Host Second Quarter 2011 Investor Conference Call 3 Adeona to Host Second Quarter 2011 Investor Conference Call 4

Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project Adeona to Host Second Quarter 2011 Investor Conference Call

(Date:5/23/2013)... On May 23, Voices Against Brain Cancer, an organization ... School senior Max Merget for turning his graduation party into ... Patch.com article, Max Merget has battled brain cancer four ... malignant tumor in the dominant, left side of brain, at ... came back a year later when he was four and ...

(Date:5/23/2013)... May 23, 2013 After working continuously ... beta testing regimes, Shopping Cart Elite officially ... Redsandmotorsports.com is an Arizona based online store retailing in ... , “Addition of new stores to our clientele has ... Cart Elite, Igor Soshkin. “We are extremely elated with ...

(Date:5/23/2013)... York (PRWEB) May 23, 2013 Spring is ... Assisi Veterinary Hospital urges pet owners to be aware of ... treatments for pet allergies. , An allergy is a state ... called an allergen. Allergen exposure may cause an over-reaction. This ... against infection and disease, can actually be harmful to the ...

(Date:5/23/2013)... 23, 2013 Ezell Law Firm is ... For 25 years, Jeff Ezell has served the ... a focus on personal injury cases . , ... insurance companies, he offers clients a uniquely qualified level ... which enables him better serve his clients. , ...

(Date:5/23/2013)... 2013 Greenville Oral & Maxillofacial ... members and doctors have recently completed their bi-annual ... an Automated External Defibrillator (AED). ... medical device designed to analyze the heart rhythm ... ventricular fibrillation to restore the heart rhythm to ...

Breaking Medicine News(10 mins):Health News:Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle 2 Health News:Shopping Cart Software Provider, Shopping Cart Elite Officially Announces the Launch Of Redsandmotorsports.com 2 Health News:Allergy Season Affects Pets as Well as People 2 Health News:Ezell Law Firm Celebrates 25 Years in Practice 2 Health News:Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification 2

[0] Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle [0] Shopping Cart Software Provider, Shopping Cart Elite Officially Announces the Launch Of Redsandmotorsports.com [0] Allergy Season Affects Pets as Well as People [0] Ezell Law Firm Celebrates 25 Years in Practice [0] Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification

... Investor Conferences in ... ... OREX ), a biopharmaceutical company focused on the treatment,of obesity ... events for November 2008, which includes,the teleconference and webcast of its ...

... Healthcare,Corporation (Nasdaq: UAHC ), which owns and ... organization in,Tennessee, today announced financial results for its ... increased five percent to $6.5 million for the ... revenues of $6.2 million for,the first quarter of ...

... 4 As biopharmaceutical,companies focus on line ... (FDC) products have become an,increasingly important segment ... better,understand the development strategies and issues for ... by Best Practices, LLC, with insights available,in ...

... HOUSTON, Nov. 4 Carriage Services, Inc.,(NYSE: CSV ) today announced results for the third quarter ended ... as follows:, Third Quarter Selected Financial Results (amounts in millions, except per share amounts), ... Q3 ... ...

... study says , , TUESDAY, Nov. 4 (HealthDay News) -- Girls ... of their movements than boys with the common mental disorder, ... Nov. 4 issue of Neurology , found that girls ... disorder did twice as well as boys with ADHD in ...

... says , , TUESDAY, Nov. 4 (HealthDay News) -- Teens ... less likely to continue using these drugs if they ... rather than short-term drug therapy, a new study found. ... be effective in treating opioid addiction, but only limited ...

Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008 United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results New Study Provides Benchmarks for Fixed-Dose Combination (FDC) Drug Development Carriage Services Announces Third Quarter 2008 Results ADHD Affects Movement More in Boys Than in Girls Extended Therapy Helps Drug-Addicted Teens

... Orion incorporates superior optics in a durable ... fully adjustable headband, made of white molded ... the brow, directing the spot along your ... the headband position the cable diagonally over ...

... of intelligent Pulse Oximeter technology. New ... over 7 years by a dedicated ... non-invasive oxygen saturation monitoring. The combination ... sophisticated saturation sensor designs using our ...

... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...

A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....

Medicine Products:

Orion Headlights OXYPLETH Pulse Oximeter TIDAL WAVE Sp Handheld Capnograph/Pulse Oximeter Score Analysis Software